Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ICU NASDAQ:MBOT NYSE:VAPO NASDAQ:VERO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICUSeaStar Medical$0.60-1.0%$0.82$0.31▼$4.49$16.81M-12.94 million shs3.68 million shsMBOTMicrobot Medical$3.22-2.1%$3.29$0.86▼$4.67$170M1.217.03 million shs2.26 million shsVAPOVapotherm$2.17$2.16$0.70▼$3.44$13.58M-1.11N/A51,531 shsVEROVenus Concept$2.32-0.4%$2.39$2.10▼$14.50$3.30M0.0921,040 shs5,763 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICUSeaStar Medical0.00%-33.22%-28.82%+48.65%-86.59%MBOTMicrobot Medical0.00%+0.94%-19.50%+28.80%+274.42%VAPOVapotherm0.00%0.00%0.00%0.00%0.00%VEROVenus Concept0.00%+1.31%+0.43%+6.42%-63.64%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeICUSeaStar Medical$0.60-1.0%$0.82$0.31▼$4.49$16.81M-12.94 million shs3.68 million shsMBOTMicrobot Medical$3.22-2.1%$3.29$0.86▼$4.67$170M1.217.03 million shs2.26 million shsVAPOVapotherm$2.17$2.16$0.70▼$3.44$13.58M-1.11N/A51,531 shsVEROVenus Concept$2.32-0.4%$2.39$2.10▼$14.50$3.30M0.0921,040 shs5,763 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceICUSeaStar Medical0.00%-33.22%-28.82%+48.65%-86.59%MBOTMicrobot Medical0.00%+0.94%-19.50%+28.80%+274.42%VAPOVapotherm0.00%0.00%0.00%0.00%0.00%VEROVenus Concept0.00%+1.31%+0.43%+6.42%-63.64%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceICUSeaStar Medical 0.00N/AN/AN/AMBOTMicrobot Medical 2.50Moderate Buy$12.00272.67% UpsideVAPOVapotherm 0.00N/AN/AN/AVEROVenus Concept 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VERO, MBOT, VAPO, and ICU Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/11/2025MBOTMicrobot MedicalHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$9.00 ➝ $12.008/21/2025MBOTMicrobot MedicalZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold(Data available from 9/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookICUSeaStar Medical$140K120.10N/AN/A($0.34) per share-1.77MBOTMicrobot MedicalN/AN/AN/AN/A$0.17 per shareN/AVAPOVapotherm$68.67M0.20N/AN/A($9.01) per share-0.24VEROVenus Concept$64.83M0.05N/AN/A$4.30 per share0.54Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateICUSeaStar Medical-$24.83M-$2.62N/A∞N/A-1,915.27%N/A-232.65%11/12/2025 (Estimated)MBOTMicrobot Medical-$11.44M-$0.58N/AN/AN/AN/A-76.27%-67.54%11/12/2025 (Estimated)VAPOVapotherm-$58.19M-$8.51N/A∞N/A-76.74%N/A-68.08%N/AVEROVenus Concept-$47M-$50.78N/A∞N/A-68.77%-871.77%-61.92%11/12/2025 (Estimated)Latest VERO, MBOT, VAPO, and ICU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025VEROVenus Concept-$9.72-$8.03+$1.69-$8.03$14.01 million$15.69 million8/13/2025Q2 2025ICUSeaStar Medical-$0.43-$0.18+$0.25-$0.18$0.25 million$0.34 million8/12/2025Q2 2025MBOTMicrobot Medical-$0.08-$0.10-$0.02-$0.10$1.00 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthICUSeaStar MedicalN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/AVAPOVapothermN/AN/AN/AN/AN/AVEROVenus ConceptN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioICUSeaStar MedicalN/A1.521.50MBOTMicrobot MedicalN/A12.0612.06VAPOVapothermN/A0.250.09VEROVenus Concept5.721.100.71Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipICUSeaStar Medical1.69%MBOTMicrobot Medical16.30%VAPOVapotherm43.08%VEROVenus Concept87.41%Insider OwnershipCompanyInsider OwnershipICUSeaStar Medical1.30%MBOTMicrobot Medical4.74%VAPOVapotherm15.80%VEROVenus Concept28.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableICUSeaStar Medical227.92 million27.55 millionNot OptionableMBOTMicrobot Medical2052.79 million50.29 millionOptionableVAPOVapotherm2906.26 million5.27 millionNo DataVEROVenus Concept4101.42 million1.03 millionNot OptionableVERO, MBOT, VAPO, and ICU HeadlinesRecent News About These CompaniesVenus Concept Secures $2M Loan for Working CapitalSeptember 22, 2025 | tipranks.comCellulite Treatment Market Size to Reach USD 5.19 Billion by 2032, Driven by Rising Demand for Non-Invasive Aesthetic Solutions | S&S InsiderSeptember 19, 2025 | globenewswire.comVenus Concept Secures Financial Relief with New AgreementsSeptember 4, 2025 | msn.comVenus Concept Secures $2M Loan for OperationsAugust 26, 2025 | tipranks.comAnalysts Conflicted on These Healthcare Names: Venus Concept (VERO) and TuHURA Biosciences (HURA)August 22, 2025 | theglobeandmail.comVenus Concept Inc. (NASDAQ:VERO) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comVenus Concept Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comVenus Concept Inc. (VERO) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comVenus Concept Amends Loan Agreements for Financial ReliefAugust 14, 2025 | theglobeandmail.comVenus Concept Announces Second Quarter 2025 Financial ResultsAugust 14, 2025 | globenewswire.comVenus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025July 16, 2025 | globenewswire.comVenus Concept Inc. to Release Q2 Fiscal 2025 Financial Results on August 14, 2025, with Conference Call DetailsJuly 16, 2025 | quiverquant.comQVERO - Venus Concept Inc Financials - MorningstarJuly 8, 2025 | morningstar.comMVenus Concept Executes Debt-to-Equity Exchange AgreementJuly 1, 2025 | tipranks.comVenus Concept Announces $6.5 Million Debt-to-Equity Exchange TransactionJuly 1, 2025 | globenewswire.comVenus Concept Inc News (VERO) - Investing.comJune 26, 2025 | investing.comVenus Concept Stock Climbs After Stock Offering ClosesJune 9, 2025 | marketwatch.comVenus Concept Inc. Closes Registered Direct Offering and Private Placement Raising Approximately $1.15 MillionJune 9, 2025 | quiverquant.comQVenus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 9, 2025 | globenewswire.comVenus Concept To Sell Hair Business To Meta Healthcare In $20M All-Cash DealJune 8, 2025 | nasdaq.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines2 Data Center REITs That Look Good in Any PortfolioBy Sam Quirke | September 8, 2025Oracle Has Spoken: AI Changes EverythingBy Thomas Hughes | September 10, 2025What NVIDIA’s Big Bet on Rival Quantinuum Means for D-Wave StockBy Nathan Reiff | September 8, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025DoorDash Buys Deliveroo: A Game Changer?By Leo Miller | September 18, 2025VERO, MBOT, VAPO, and ICU Company DescriptionsSeaStar Medical NASDAQ:ICU$0.60 -0.01 (-1.00%) Closing price 09/26/2025 04:00 PM EasternExtended Trading$0.60 0.00 (-0.53%) As of 09/26/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.Microbot Medical NASDAQ:MBOT$3.22 -0.07 (-2.13%) Closing price 09/26/2025 04:00 PM EasternExtended Trading$3.20 -0.03 (-0.78%) As of 09/26/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Vapotherm NYSE:VAPOVapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.Venus Concept NASDAQ:VERO$2.32 -0.01 (-0.43%) Closing price 09/26/2025 04:00 PM EasternExtended Trading$2.28 -0.04 (-1.72%) As of 09/26/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/22 - 09/26 Get Exposure to Millennials' Purchasing Power With This ETF Beam Global Gets Buy Rating With 101% Upside Potential Institutional Buying Sets a High Floor for Microsoft Stock High-Momentum ETFs to Mine for Gold, Silver, and Bitcoin It's a Good Time to Build a Position in KB Home Alphabet: Time to Take Profits, Buy, or Wait for a Pullback? NuScale, Rocket Lab Face Heavy Insider Selling After Surges Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
